SUMMARY T lymphocyte subset percentages were determined in 16 total lymphoid irradiation (TLI) treated and 18 sham treated control patients with chronic progressive multiple sclerosis. During the first year after treatment, the ratio of T helper/inducer to T suppressor/cytotoxic cells (Th/Ts ratio) was significantly higher in sham treated multiple sclerosis patients who worsened clinically compared with TLI treated and sham treated multiple sclerosis patients who remained clinically stable. TLI caused a fall in the percentage of T helper cells in treated patients, while the percentage of T suppressor cells remained stable during the first year after treatment. In contrast, the percentage of T suppressor cells fell in sham treated multiple sclerosis patients who worsened clinically.
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Total lymphoid irradiation (TLI) has proven to be an effective and relatively safe method of inducing sustained immunosuppression in patients with inflammatory diseases of putative autoimmune aetiology.' 7 In these patients, TLI has caused a significant decrease in the absolute lymphocyte count, and the percentage of helper/inducer T cells, with a decreased ratio of helper to suppressor T lymphocytes (Th/Ts ratio) which has persisted for up to 4 years following radiotherapy.7
In this report, we present the results of determinations of T lymphocyte subsets in TLI treated chronic progressive multiple sclerosis patients and their sham treated controls.
The design of the multiple sclerosis TLI study has been described in detail elsewhere.8 In a double blind study, 40 patients with chronic progressive multiple sclerosis were randomised into either a TLI treatment group or a control group treated with a sham TLI protocol. Patients were well matched for sex, age and duration of disease.
Immediately before treatment the patients were scored clinically on a practical functional scale. Following treatment the patients were evaluated and scored at monthly intervals for 6 months and then every 3 months. Immediately before treatment and periodically after treatment, blood was obtained to measure T lymphocyte helper and suppressor subsets. Samples were missed in patients who entered the study very early before lymphocyte testing was begun and in patients who missed appointments or were dropped out of the study because of severe progression or other reasons which are discussed in a previous detailed report. 8 
